Clinical Trials - Public Availability of Results
This data visualization shows what portion of clinical trials in multiple sclerosis have made their results publicly available on clinicaltrials.gov.
Comparison of MS trials baseline characteristics
NMO History
Episode 98 with Dr. David Baker on the use of animal models in medical research
Animal models can be instrumental in informing our knowledge and treatment of human disease -- when they're used correctly, that is. Dr. David Baker (aka the "Mouse Doctor") returns for part 2 of his interview, sharing his tips for the correct use of EAE and models in general.
<
Drug Development, Laboratory Research
Episode 97 with Dr. David Baker on MS drug development and trial design
The process of taking a drug from bench to bedside is often challenging but always enlightening. In the first installment of a 2-part interview, Dr. David Baker shares what he's learned in his work developing new drugs for MS.
<
Drug Development
Episode 96 with Drs. Bibiana Bielekova and Mika Komori on a new CSF biomarker for MS
Analysis of cerebrospinal fluid from people with MS led to a surprising result, one which has intriguing implications for understanding and treating progressive MS.
<
Clinical Research
Episode 95 with Dr. Michael Levy on T cells in neuromyelitis optica
The discovery of pathogenic antibodies led to an important new understanding of NMO and its diagnosis -- could T cells hold the key to the treatment of this disease?
<
Laboratory Research
Episode 94 with Dr. Oscar Fernandez on evaluating DMT risk in MS
Clinicians must carefully balance the risks and benefits of MS DMTs for each patient. Fortunately, there are tools, knowledge and research findings to help with this process. Dr. Fernandez describes the approaches he uses to perform this balancing act with his patients.
Clinical Research
Episode 93 with Dr. Lilyana Amezcua on MS in the Hispanic community
Rich in diversity, the MS Hispanic community is a valuable resource for researchers studying how genetic, environmental and cultural backgrounds influence MS risk and clinical characteristics.
Clinical Research
Episode 92 with Dr. Shiv Saidha on using OCT to understand MS
If the eye is the window to the soul, could it also give us a glimpse into the brain? Dr. Saidha explains the evolving use of optical coherence tomography to measure how MS affects retinal and optic nerves, and where else this might lead us.
Clinical Research
Pages
